SMUP-IA-01

Completed Phase 1 clinical trial in Korea60%
60%

Intra-articular Injectable treatment for osteoarthritis

SMUP-IA-01, SMUP allogeneic umbilical cord blood-derived mesenchymal stem cells, is currently under development for the treatment and prevention of Osteoarthritis. Currently, Phase 1 clinical trial has been completed as of November 2020 in Korea.

Mechanism of Action for SMUP-IA-01

Related News

Menu